Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseRandall J. Bateman, John C. Morris, Chengjie Xiong et al.|New England Journal of Medicine|2012Cited by 3.8k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseStephen Salloway, H. Robert Brashear, Reisa A. Sperling et al.|New England Journal of Medicine|2014Cited by 2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Cliff R Jack, Harald Hampel et al.|Alzheimer s & Dementia|2016Cited by 1.9k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseMathias Jucker, Jasmeer P. Chhatwal, Alison Goate et al.|Nature Medicine|2019Cited by 948
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Reisa A. Sperling et al.|Neurology|2009Cited by 739